cover of episode A Goal Too Far: Rethinking HbA1c Targets for Diabetes Treatment

A Goal Too Far: Rethinking HbA1c Targets for Diabetes Treatment

2018/6/19
logo of podcast JAMA Clinical Reviews

JAMA Clinical Reviews

Shownotes Transcript

The American College of Physicians just changed its guidance for how aggressively to treat type 2 diabetes, relaxing the HbA1c goal to something below 8 rather than 6.5 or 7 as other organizations recommend. This has stirred up substantial controversy. The rationale behind this decision is presented in this podcast.

Related article)